Aptose Biosciences, Inc.
APTO
APTO was delisted on the 1st of April, 2025.
24 hedge funds and large institutions have $1.72M invested in Aptose Biosciences, Inc. in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 3 closing their positions.
4% less funds holding
Funds holding: 25 → 24 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
47% less capital invested
Capital invested by funds: $3.25M → $1.72M (-$1.53M)
88% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$212K |
| 2 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$40.7K |
| 3 |
PP
PDS Planning
Dublin,
Ohio
|
+$19.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$277K |
| 2 |
CC
Carlson Capital
Dallas,
Texas
|
-$246K |
| 3 |
AC
Annandale Capital
Dallas,
Texas
|
-$91.5K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$69.1K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$60.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citigroup
New York
| $2 | – | – | – |
|
27
Fidelity International
Hamilton,
Bermuda
| $2 | – | – | – |
|
28
National Bank of Canada
Montreal,
Quebec, Canada
| $1 | – | – | – |
|
|
CC
29
Carlson Capital
Dallas,
Texas
| – | -$246K | -3,222 | Closed |
|
|
TSS
30
Two Sigma Securities
New York
| – | -$39.3K | -516 | Closed |
|
31
UBS Group
Zurich,
Switzerland
| – | -$19.3K | -253 | Closed |
|
APTO Hedge Fund Activity: Q1 2024 in Review
24 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q1 2024, worth a combined $1.72M — down 47% from $3.25M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of APTO and 2 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 1 added.
The largest buyer was Sigma Planning Corp, adding an estimated $212K. The largest seller was Morgan Stanley, cutting an estimated $277K.
- 24 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q1 2024, down from 25 in Q4 2023.
- Funds reported $1.72M of Aptose Biosciences, Inc. stock for Q1 2024, down 47% quarter-over-quarter.
- 2 funds opened new Aptose Biosciences, Inc. positions in Q1 2024 and 3 closed out, a net change of -1 holder.
- The largest Aptose Biosciences, Inc. buyer in Q1 2024 was Sigma Planning Corp, an estimated $212K added.
- The largest Aptose Biosciences, Inc. seller in Q1 2024 was Morgan Stanley, an estimated $277K sold.
Based on aggregated 13F filings for Q1 2024.